Table1 Clinical data  $R e c$  recurrence,Met metastasis,  $P_{F}$  primary, Tmf temporomandibular fossa, Smr submandibular region,  $S$  surgery,  $R$  radiation therapy,  $C$  chemotherapy,URprimary site of   
tumor unresectable,  $L$  regional lymph node metastasis,  $D$  distant metastasis,  $A o$  alive without disease,  $A c$  alive with disease,  $D c$  died of disease)   


<td><table  border="1"><thead><tr><td><b>Case no.</b></td><td><b>Diagnosis</b></td><td><b>Case</b></td><td><b>Sex</b></td><td><b>Age (years)</b></td><td><b>Site</b></td><td><b>Treatment</b></td><td><b>Rec</b></td><td><b>Met</b></td><td><b>Follow-up</b></td><td><b>Status</b></td></tr></thead><tbody><tr><td>1</td><td>Osteosarcoma</td><td>Pr</td><td>M</td><td>25</td><td>Tmf</td><td>S+R+C</td><td>一</td><td>一</td><td>7 years 1 month</td><td>Ao</td></tr><tr><td>2</td><td>Osteosarcoma</td><td>Pr</td><td>F</td><td>34</td><td>Maxilla</td><td>S</td><td>一</td><td>一</td><td>9 years 6 months</td><td>Ao</td></tr><tr><td>3</td><td>Osteosarcoma</td><td>Pr</td><td>F</td><td>40</td><td>Mandible</td><td>S</td><td>+</td><td>一</td><td>6 years 4 months</td><td>Ao</td></tr><tr><td>4</td><td>Osteosarcoma</td><td>Pr</td><td>M</td><td>46</td><td>Mandible</td><td>S</td><td>一</td><td>D</td><td>5 years</td><td>Dc</td></tr><tr><td>5</td><td>Osteosarcoma</td><td>Pr</td><td>M</td><td>50</td><td>Mandible</td><td>S</td><td>+</td><td>D</td><td>13 years 7 months</td><td>Ac</td></tr><tr><td>6</td><td>Osteosarcoma</td><td>Pr</td><td>M</td><td>50</td><td>Maxilla</td><td>S+C</td><td>一</td><td>一</td><td>3years 2months</td><td>Ao</td></tr><tr><td>7</td><td>Osteosarcoma</td><td>Rec</td><td>M</td><td>56</td><td>Maxillary sinus</td><td>S+R+C</td><td>+</td><td>一</td><td>4 years 1 month</td><td>Dc</td></tr><tr><td>8</td><td>Osteosarcoma</td><td>Rec</td><td>F</td><td>63</td><td>Maxilla</td><td>S+R+C</td><td>一</td><td>D</td><td>3years 3months</td><td>Dc</td></tr><tr><td>9</td><td>Osteosarcoma</td><td>Rec</td><td>M</td><td>67</td><td>Mandible</td><td>S</td><td>一</td><td>一</td><td>9 years 3 months</td><td>Ao</td></tr><tr><td>10</td><td>MFH</td><td>Pr</td><td>M</td><td>29</td><td>Maxillary sinus</td><td>S+C</td><td>+</td><td>一</td><td>1 year 4 months</td><td>Dc</td></tr><tr><td>11</td><td>MFH</td><td>Pr</td><td>M</td><td>43</td><td>Mandible</td><td>S</td><td>+</td><td>L</td><td>2 years</td><td>Dc</td></tr><tr><td>12</td><td>MFH</td><td>Pr</td><td>M</td><td>45</td><td>Smr</td><td>S+R</td><td>一</td><td>一</td><td>8years 1 month</td><td>Ao</td></tr><tr><td>13</td><td>MFH</td><td>Rec</td><td>M</td><td>48</td><td>Mandible</td><td>S</td><td>一</td><td>一</td><td>4 years 6 months</td><td>Ao</td></tr><tr><td>14</td><td>MFH</td><td>Pr</td><td>M</td><td>56</td><td>Maxilla</td><td>S+R+C</td><td>一</td><td>一</td><td>11 years 8 months</td><td>Ao</td></tr><tr><td>15</td><td>MFH</td><td>Pr</td><td>M</td><td>57</td><td>Maxillary sinus</td><td>S</td><td>+</td><td>L</td><td>9months</td><td>Dc</td></tr><tr><td>16</td><td>MFH</td><td>Pr</td><td>M</td><td>63</td><td>Maxillary sinus</td><td>S+R+C</td><td>一</td><td>一</td><td>5 years</td><td>Ao</td></tr><tr><td>17</td><td>Rhabdomyosarcoma</td><td>Pr</td><td>M</td><td>11</td><td>Buccal mucosa</td><td>S</td><td>+</td><td>一</td><td>17 years 3months</td><td>Ao</td></tr><tr><td>18</td><td>Rhabdomyosarcoma</td><td>Pr</td><td>F</td><td>27</td><td>Buccal mucosa</td><td>S+R+C</td><td>一</td><td>D</td><td>1year 6months</td><td>Dc</td></tr><tr><td>19</td><td>Rhabdomyosarcoma</td><td>Pr</td><td>M</td><td>55</td><td>Maxilla</td><td>S+C</td><td>一</td><td>D</td><td>2 years 3 months</td><td>Dc</td></tr><tr><td>20</td><td>Rhabdomyosarcoma</td><td>Pr</td><td>M</td><td>58</td><td>Maxilla</td><td>C+R</td><td>UR</td><td>L+D</td><td>4months</td><td>Dc</td></tr><tr><td>21</td><td>Rhabdomyosarcoma</td><td>Pr</td><td>M</td><td>77</td><td>Mandible</td><td>S</td><td>一</td><td>一</td><td>2 years 9 months</td><td>Ao</td></tr><tr><td>22</td><td>Fibrosarcoma</td><td>Pr</td><td>F</td><td>5m</td><td>Mandible</td><td>S+C</td><td>一</td><td>一</td><td>9 years 9 months</td><td>Ao</td></tr><tr><td>23</td><td>Fibrosarcoma</td><td>Pr</td><td>F</td><td>10</td><td>Mandible</td><td>S</td><td>一</td><td>一</td><td>11 years 6 months</td><td>Ao</td></tr><tr><td>24</td><td>Fibrosarcoma</td><td>Pr</td><td>F</td><td>16</td><td>Mandible</td><td>S</td><td>一</td><td>一</td><td>19 years</td><td>Ao</td></tr><tr><td>25</td><td>Plasmacytoma</td><td>Pr</td><td>M</td><td>53</td><td>Mandible</td><td>S+R</td><td>一</td><td>一</td><td>14 years</td><td>Ao</td></tr><tr><td>26</td><td>Plasmacytoma</td><td>Pr</td><td>M</td><td>59</td><td>Maxillary sinus</td><td>S+R</td><td>一</td><td>一</td><td>5 years 1 month</td><td>Ao</td></tr><tr><td>27</td><td>Leiomyosarcoma</td><td>Rec</td><td>M</td><td>25</td><td>Maxilla</td><td>C+R</td><td>UR</td><td>L+D</td><td>2months</td><td>Dc</td></tr><tr><td>28</td><td>Leiomyosarcoma</td><td>Pr</td><td>M</td><td>43</td><td>Mandible</td><td>S</td><td>一</td><td>D</td><td>8 years</td><td>Ac</td></tr><tr><td>29</td><td>Angiosarcoma</td><td>Pr</td><td>M</td><td>34</td><td>Tmf</td><td>C+R</td><td>UR</td><td>一</td><td>4 years</td><td>Dc</td></tr><tr><td>30</td><td>Angiosarcoma</td><td>Pr</td><td>M</td><td>53</td><td>Maxilla</td><td>S+R</td><td>+</td><td>L</td><td>8months</td><td>Dc</td></tr><tr><td>31</td><td>Liposarcoma</td><td>Pr</td><td>F</td><td>33</td><td>Buccal mucosa</td><td>S</td><td>+</td><td>一</td><td>2 years 10 months</td><td>Dc</td></tr><tr><td>32</td><td>Ameloblastic fibro- sarcoma</td><td>Rec</td><td>M</td><td>31</td><td>Mandible</td><td>S</td><td>+</td><td>一</td><td>5months</td><td>Dc</td></tr></tbody></table></td>  

Themostcommonhistological typewas osteosarcoma  $\scriptstyle{n=9}$   $28\%$  followed by malignant fibrous histiocytoma (MFH;  $n{=}7$   $22\%$  rhabdomyosarcoma  $(n{=}5,\,16\%)$  ,fibrosarcoma  $(n{=}3,\,9\%)$  ,plasma- cytoma  $(n\!=\!2,\,6\%)$  ,leiomyosarcoma  $(n{=}2,\,6\%)$  ,angiosarcoma  $n{=}2$   $6\%)$  ,andliposarcoma  $(n{=}1,\,3\%)$  ,ameloblasticfibrosarcoma  $_n{=}1$   $3\%$  .Thehistological subtypesofosteosarcoma were chondroblastic  $n{=}5$  Table 1,nos.1,2,6,8,9),osteoblastic  $\scriptstyle{n=3}$  nos.3,4, 7),and telangiectatic  $_{n=1}$  ,no.5).In rhabdomyosarcoma,the histologicalsubtypes werealveolar  $_n{=}3$  ，nos.17,18,20) and pleomorphic  $n{=}2$  nos.19,21).Patients with malignant lymphoma were excludedfrom this studybecausemalignantlymphomais a systemic disease.Twocasesofplasmacytomawerebothofthe solitary type,thereforethesecaseswereincluded.  

Surgicalresection(S)alone was carried out in 15patients. Triple modality of S,radiation therapy (R) and chemotherapy (C) wasperformedin6,combined therapyof  $S/C$  in4,and  $S/\mathbb{R}$  wasin 4.We judged that the primary tumors were unresectable in three cases;therefore combined therapy of R and Cwasgiven tothese3 patients.Radiation therapy was given preoperatively in 6 cases, postoperatively in3 and both in 1. The doses usedvaried from 18 to  $80\,\mathrm{Gy}$  with an average of48 Gy.All radiationtherapywasexternal irradiation.The fraction sizes were  $2.5\ \mathrm{Gy}$  treating4daysina week.Chemotherapy wasgiven preoperatively in 8 cases and postoperatively in 2. The chemotherapy regimens were varied.  

Treatmentwas determined according tothe experience ofthe surgeon. This resulted in a lack of unity in the treatment protocol. The common agents were cisplatin  $(n=5)$  ,5-fluorouracil  $(n=4)$  ,and doxorubicin  $(n{=}4)$  The regional intra-arterial infusion chemotherapy administeredvia the superficial temporal arterywasgiven in 9 of 11 patients who had sarcoma of themaxilla,maxillary sinus,or thetemporomandibularfossa.Thesurvivalrateandsurvivalcurve were calculated by the Kaplan-Meiermethod usingSPSS for Windows,version10.  

# Results  

Fourteen patients of 32 were making satisfactory progress without local recurrence or metastasis at a meanfollow-up period of 8.5 years, ranging from 2 years 3 months to 19years.Localrecurrencewas found in10cases  $(31\%)$  andmetastasis in 11  $(34\%)$  .Among 10patientswithlocal recurrence,3 are alive after6-17years,and7diedoftheir tumors after 5 months to 4 years. Among the 3 patients alive, one (no. 3) was treated by surgery and the other (no. 17)bysurgery andpostoperativeradiation therapy  $(50\,\mathrm{Gy})$  after local recurrencewas found.These twopatients are alivewithout evidence ofdisease over3years and7years after salvage treatment.Another patient (no.5) was treated bypreoperativeradiation therapy(45 Gy) andsurgeryfor local recurrence.The local recurrence was controlled,but this patient developed distant metastasis to the lung.  

The5-yearsurvivalrateofpatientwithlocalrecurrence was  $30\%$  (Fig.1).Among 11patientswith metastases9 died  